In case you have not been following the story very closely, the debate over biotech wheat is about to restart again. Cereal breeding in North America has been on the downtrend. The past three months have brought wheat breeding investments by Dow Agro, Monsanto and Bayer. These strategic moves are quite obviously being executed so that beneficial proprietary traits can be inserted into wheat genetics. As mentioned before on this site, many possibilities open up to the consumer and not just the farmer if biotech wheat is introduced. At the International Livestock Congress at the Calgary Stampede, Earl Geddes and I discussed the future direction of wheat breeding and how biotech wheat may lead us there.
This week, winter wheat prices touched a three-year high, but it didn’t last. Chicago SRW wheat prices for September 2018 gained 5 per cent or about 26 cents US/bushel to close at $5.56. While the December 2018 contract was up 5.4 percent — or nearly 30 cents — to finish a tad under $5.80. In…Read more »